Wolf W - Search Results

1

Noninvasive methods to study drug distribution.

Port RE, Wolf W. Port RE, et al. Among authors: wolf w. Invest New Drugs. 2003 May;21(2):157-68. doi: 10.1023/a:1023569328717. Invest New Drugs. 2003. PMID: 12889737 Review.

2

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Presant CA, Jacobson J, Wolf W, Waluch V, Weitz IC, Macdonald JS; Southwest Oncology Group. Presant CA, et al. Among authors: wolf w. Invest New Drugs. 2002 Nov;20(4):369-76. doi: 10.1023/a:1020651311866. Invest New Drugs. 2002. PMID: 12448653 Clinical Trial.

3

Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.

Presant CA, Wolf W, Waluch V, Wiseman CL, Weitz I, Shani J. Presant CA, et al. Among authors: wolf w. J Clin Oncol. 2000 Jan;18(2):255-61. doi: 10.1200/JCO.2000.18.2.255. J Clin Oncol. 2000. PMID: 10637237 Clinical Trial.

4

Introduction and overview of noninvasive drug monitoring.

Wolf W. Wolf W. Adv Drug Deliv Rev. 2000 Mar 15;41(1):1-5. doi: 10.1016/s0169-409x(99)00052-6. Adv Drug Deliv Rev. 2000. PMID: 10699301 No abstract available.

5

Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors.

Dowell JA, Sancho AR, Anand D, Wolf W. Dowell JA, et al. Among authors: wolf w. Adv Drug Deliv Rev. 2000 Mar 15;41(1):111-26. doi: 10.1016/s0169-409x(99)00059-9. Adv Drug Deliv Rev. 2000. PMID: 10699308 Review.

6

The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS.

Wolf W. Wolf W. Pharm Res. 2011 Mar;28(3):490-3. doi: 10.1007/s11095-010-0293-5. Epub 2010 Oct 1. Pharm Res. 2011. PMID: 20886263 Review. No abstract available.

7

19F-MRS studies of fluorinated drugs in humans.

Wolf W, Presant CA, Waluch V. Wolf W, et al. Adv Drug Deliv Rev. 2000 Mar 15;41(1):55-74. doi: 10.1016/s0169-409x(99)00056-3. Adv Drug Deliv Rev. 2000. PMID: 10699305 Review.

8

Association of intratumoral pharmacokinetics of fluorouracil with clinical response.

Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, Brechner RR. Presant CA, et al. Among authors: wolf w. Lancet. 1994 May 14;343(8907):1184-7. doi: 10.1016/s0140-6736(94)92399-x. Lancet. 1994. PMID: 7909867

9

Non-invasive 19F-NMRS of 5-fluorouracil in pharmacokinetics and pharmacodynamic studies.

Wolf W, Waluch V, Presant CA. Wolf W, et al. NMR Biomed. 1998 Nov;11(7):380-7. doi: 10.1002/(sici)1099-1492(1998110)11:7<380::aid-nbm517>3.0.co;2-q. NMR Biomed. 1998. PMID: 9859944

10

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

Presant CA, Wolf W, Albright MJ, Servis KL, Ring R 3rd, Atkinson D, Ong RL, Wiseman C, King M, Blayney D, et al. Presant CA, et al. Among authors: wolf w. J Clin Oncol. 1990 Nov;8(11):1868-73. doi: 10.1200/JCO.1990.8.11.1868. J Clin Oncol. 1990. PMID: 2230874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

758 results

Search Page